纤溶酶联合血栓通粉针治疗早期脑梗死临床分析  

作　　者：哈斯高娃[1] 曹中朝[1] 

机构地区：[1]内蒙古医学院第一附属医院保健中心,010059

出　　处：《中国社区医师（医学专业）》2012年第28期176-177,共2页

摘　　要：目的:探讨纤溶酶联合血栓通治疗早期脑梗死的临床疗效。方法:将68例早期脑梗死患者随机分为对照组和治疗组,每组34例。对照组给予纤溶酶治疗14天,治疗组给予纤溶酶联合血栓通治疗14天,评定两组临床效果。结果:两组总有效率比较差异有统计学意义(P<0.05)。结论:纤溶酶联合血栓通治疗早期脑梗死能够显著改善早期脑梗死患者神经功能,临床治疗效果显著,值得临床借鉴。Objective： To explore the clinical effect of plasmin and Xueshuantong injection on early cerebral infarction. Methods：68 ca- ses of early cerebral infarction were random- ly divided into the control group and the treatment group ,34 eases in each group. The control group was treatedwith Xueshuantong injection for 14 days, but the treatment group was treated with plasmin and Xue- shuantong injection for 14 days. Then the clinical effects of two groups were evalua- ted. Results：There were significant differ- ences between the control group and the treatment group on the total effective rate e- qual （ P 〈 0. 05 ）. Conclusion ： The plasmin and Xueshuantong early treatment the cere- bral infarction can improve the early cere- bral infarction with neural function, clinical treatment effect is remarkable, and clinical using for reference.

关 键 词：纤溶酶 血栓通 早期脑梗死 

分 类 号：R743.33[医药卫生—神经病学与精神病学]